
    
The genomic variant c.797A>G p.Glu266Gly, designated as rs1489788269, is located in the ALOXE3 gene. This missense variant results in the substitution of glutamic acid with glycine at the 266th amino acid position of the protein. The ALOXE3 gene encodes an enzyme that is a member of the lipoxygenase family and plays a critical role in the epidermal differentiation complex, which is essential for skin barrier function and integrity. Specifically, ALOXE3 is involved in the metabolism of fatty acids in the skin, contributing to the formation of lipid-based barrier structures.The clinical significance of the c.797A>G p.Glu266Gly variant in ALOXE3 has been evaluated in the context of hereditary ichthyosis, a group of disorders characterized by dry, thickened, and scaly skin. However, this particular variant has been classified as a variant of uncertain significance, indicating that its impact on the ALOXE3 protein function and its contribution to hereditary ichthyosis are not yet fully understood [1]. The variant's classification is based on a single submission in ClinVar, which reflects the need for further research and additional evidence to establish its pathogenicity or lack thereof.Given the role of ALOXE3 in skin health, variants within this gene can potentially disrupt normal skin barrier formation and maintenance, leading to clinical manifestations associated with ichthyosis. However, without more definitive functional studies or additional genetic evidence, the pathogenicity of the c.797A>G p.Glu266Gly variant remains uncertain. Further genetic analysis, such as segregation studies within affected families and functional assays, would be necessary to clarify the clinical relevance of this variant and its potential role in hereditary ichthyosis.

ゲノム変異 c.797A>G p.Glu266Gly（rs1489788269）は、ALOXE3遺伝子に位置しています。このミスセンス変異は、タンパク質の266番目のアミノ酸であるグルタミン酸がグリシンに置換される結果をもたらします。ALOXE3遺伝子はリポキシゲナーゼファミリーに属する酵素をコードしており、皮膚バリア機能とその完全性に不可欠な表皮分化複合体において重要な役割を果たします。具体的には、ALOXE3は皮膚内の脂肪酸代謝に関与し、脂質ベースのバリア構造の形成に寄与しています。

ALOXE3のc.797A>G p.Glu266Gly変異の臨床的意義は、乾燥、肥厚、鱗状の皮膚を特徴とする遺伝性魚鱗癬の文脈で評価されています。しかし、この特定の変異は「意義不明の変異」と分類されており、ALOXE3タンパク質機能への影響や遺伝性魚鱗癬への寄与はまだ完全には理解されていません[1]。この変異の分類はClinVarでの単一の提出に基づいており、その病原性または非病原性を確立するためにはさらなる研究と追加の証拠が必要であることを示しています。

ALOXE3が皮膚の健康に果たす役割を考えると、この遺伝子内の変異は正常な皮膚バリアの形成と維持を妨げ、魚鱗癬に関連する臨床症状を引き起こす可能性があります。しかし、より決定的な機能研究や追加の遺伝的証拠がない限り、c.797A>G p.Glu266Gly変異の病原性は不確定のままです。この変異の臨床的関連性と遺伝性魚鱗癬への潜在的な役割を明確にするためには、影響を受けた家族内での分離研究や機能アッセイなどのさらなる遺伝的解析が必要です。
    
## References
- [1] Chegini M et al. (2023). "Whole exome sequencing identifies novel pathogenic variants in TGM1 and ALOX12B in patients with hereditary ichthyosis." Archives of dermatological research, 316(1) [PubMed](https://pubmed.ncbi.nlm.nih.gov/38060040/)

    
## ClinVar Submissions
- **[RCV003249438](https://www.ncbi.nlm.nih.gov/clinvar/RCV003249438/)**: Inborn genetic diseases

    